Diligence memo · auto-generated · as of July 3, 2026
ClearLight Biotechnologies, LLC
ClearLight Biotechnologies, LLC has raised $8.8M over 3 rounds; too few niche peers to rank its valuation yet.
Businessfiled
ClearLight Biotechnologies, LLC operates in Biotech / Pharma, based in SUNNYVALE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
ClearLight Biotechnologies, LLC has raised $8.8M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.5M on 2016-10-25.
Most recent recorded round closed around 2018-02-02.
Valuation (modeled)modeled
Provath models ClearLight Biotechnologies, LLC at approximately $114M (range $2.0M–$893M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 14 months.
Last raise 8.4 yr ago; this sector typically re-raises about every 15 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.3× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 59% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 72% of those peers.
Closest niche peers: Recreo Pharmaceuticals Llc, Vivacelle Bio, Inc., Base Pair Biotechnologies, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.